Optomed’s January–September 2020 Interim Report to be published on 25 Nov 2020
Optomed Plc, Press Release, 17 November 2020 at 14.00, Helsinki
Optomed’s January–September 2020 Interim Report to be published on 25 November 2020
Optomed will publish its January–September 2020 Interim Report on 25 November 2020 approximately at 9.00 EET.
A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EET at the latest. The participants are requested to register for the call in advance by email to firstname.lastname@example.org.
Please see the call-in numbers below:
FI +358 9 8562 6300
SE +46 8 505 218 52
UK +44 20 3321 5273
US +1 646 838 1719
FR +33 1 70 99 53 92
The conference id is 346 945 274#.
Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.
Sakari Knuutti, CLO, Optomed Plc, email@example.com, +358 50 562 4077
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 565 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and Optomed employed 108 professionals the end of 2019.